Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps in premarket - CNBC


12/20/2024

Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps in premarket  CNBCNovo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar.  Barron'sWhy Novo Nordisk (NVO) Is Plummeting Today  Yahoo FinanceNovo Nordisk Falls Most on Record After New Weight Drug Disappoints  BloombergNovo Nordisk’s drug stumble leaves it suddenly much slimmer  Financial Times...

Original

Tags: cnbc | drug | falls | record | shares | stock | times | trial



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top